You are here

Clinical Trials: Heart Disease



Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, March 15, 2019 - 12:00
Condition:   Primary Ovarian Insufficiency
Intervention:   Genetic: Cell therapy
Sponsors:   Chinese Academy of Sciences;   The First Affiliated Hospital of Zhengzhou University;   National Natural Science Foundation of China
Posted: Tuesday, February 12, 2019 - 12:00
Condition:   Exercise
Intervention:   Behavioral: Types of Exercise
Sponsors:   East Carolina University;   American Heart Association
Posted: Wednesday, January 9, 2019 - 12:00
Condition:   Myocardial Infarction
Interventions:   Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.;   Procedure: Surgery by sternotomy
Sponsors:   Fundació Institut Germans Trias i Pujol;   Germans Trias i Pujol Hospital
Not yet recruiting
Posted: Tuesday, January 8, 2019 - 12:00
Condition:   Non-ischemic Dilated Cardiomyopathy
Interventions:   Biological: Allogeneic adipose-derived stromal cells (CSCC_ASC);   Other: Control group
Sponsors:   JKastrup;   University Medical Centre Ljubljana
Not yet recruiting
Posted: Wednesday, December 19, 2018 - 12:00
Condition:   Hypoplastic Left Heart Syndrome
Interventions:   Biological: Autologous (self) mononuclear cells derived from umbilical cord blood;   Procedure: Stage II Surgical repair
Sponsors:   Timothy J. Nelson;   University of Oklahoma;   Children's Hospital of Philadelphia;   Children's Hospital Los Angeles;   Children's Hospital Colorado;   Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Posted: Friday, December 14, 2018 - 12:00
Conditions:   Heart Failure;   Growth Hormone Deficiency
Interventions:   Drug: Human growth hormone;   Other: Placebo
Sponsor:   Federico II University
Not yet recruiting
Posted: Monday, December 3, 2018 - 12:00
Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Dietary Supplement: Trans-resveratrol;   Dietary Supplement: Placebo
Sponsors:   Maine Medical Center;   American Heart Association
Posted: Tuesday, November 20, 2018 - 12:00
Condition:   Heart Failure With Reduced Ejection Fraction
Intervention:   Device: VB-C01
Sponsors:   Viscofan;   Ministerio de Ciencia e Innovación, Spain
Posted: Thursday, October 4, 2018 - 12:00
Condition:   Cardiomyopathy, Familial
Interventions:   Other: Electrocardiogram;   Other: physical examination;   Other: echocardiography;   Biological: blood test
Sponsor:   University Hospital, Montpellier
Posted: Thursday, June 28, 2018 - 12:00
Condition:   Dilated Cardiomyopathy
Intervention:   Biological: Bone marrow derived mononuclear cells and G-CSF
Sponsor:   Barts & The London NHS Trust
Not yet recruiting